Skip to main content
Log in

The diagnostic value of serum pancreatic phospholipase A2 (PLA2) in pancreatic diseases

  • Liver, Pancreas and Biliary Tract
  • Published:
Gastroenterologia Japonica Aims and scope Submit manuscript

Summary

The diagnostic significance of serum immunoreactive pancreatic phospholipase A2 (PLA2) was studied in 119 patients with pancreatic disease, 200 with various non-pancreatic disease, and 203 healthy controls using radioimmunoassay (RIA) specific to human pancreatic PLA2. This newly developed RIA using monoclonal antibody was satisfactorily sensitive and reliable. Serum PLA2 was elevated in all six patients with acute pancreatitis. Frequency of abnormal serum PLA2 levels was 60% in chronic pancreatitis (n=52) and 67% in pancreatic cancer (n=61). Serum PLA2 levels were low in chronic pancreatitis with severe exocrine insufficiency and advanced pancreatic cancer. In chronic pancreatitis, patients with low serum PLA2 level showed lower enzyme output in secretin test than patients with normal or high serum PLA2 level. Frequency of abnormal PLA2 levels was 27% in non-pancreatic disease and, in particular, patients with renal failure showed high PLA2 levels. Sensitivity (62%) and efficiency (69%) of serum PLA2 assay in pancreatic disease were superior to those of amylase. In conclusion, serum PLA2 determination using RIA was useful for the diagnosis of acute pancreatitis by high serum PLA2 levels and the diagnosis of severe exocrine pancreatic insufficiency by low serum PLA2 levels.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Schmidt H, Creutzfeldt W: The possible role of phospholipase A in the pathogencsis of acute pancreatitis. Scand J Gastroenterol 1969;4:39–48

    Article  PubMed  CAS  Google Scholar 

  2. Schroder T, Kivilaakso E, Kinnuncn PKJ, et al: Serum phospholipase A2 in human acute pancreatitis. Scand J Gastroenterol 1980; 15:633–636

    PubMed  CAS  Google Scholar 

  3. Nevalainen TJ, Aho HJ: Phospholipase A2 in acute pancreatitis. In: Berger HG. Bucher M, eds. Acute pancreatitis. Springer-Verlag, Berlin. 1987;71–78

    Google Scholar 

  4. Nevalainen TJ: Phospholipase A2 in acute pancreatitis. Scand J Gastrocnterol 1988;23:897–904

    Article  CAS  Google Scholar 

  5. Hashihira S, Nishii T, Takeda Y, et al: Serum phospholipase A in patients with acute pancreatitis. Jpn Arch Intern Med 1977;24:243–249

    CAS  Google Scholar 

  6. Nevalaincn TJ, Eskola JU, Aho AJ, et al: Immunoreactivc phospholipase A2 in serum in acute pancreatitis and pancreatic cancer. Clin Chcm 1985;31:1116–1120

    Google Scholar 

  7. Matsuda Y, Ogawa M, Nishijima K, et al: Usefulness of determination of serum immunoreactive pancreatic phospholipase A2 content for early identification of severe acute pancreatitis. Hepato-gastroenterol 1986;33:214–216

    CAS  Google Scholar 

  8. Zieve L, Vogel MC: Measurement of lecithinasc A in serum and other body fluid. J Lab Clin Med 1961;57:586–599

    PubMed  CAS  Google Scholar 

  9. Doizaki WM, Zieve L: Turbidimetric serum phospholipase A activity in acute pancreatitis. J Lab Clin Med 1966;67:108–115

    PubMed  CAS  Google Scholar 

  10. Nishijima J, Okamoto M, Ogawa M, et al: Purification and characterization of human pancreatic phospholipase A2 and development of a radioimmunoassay. J Biochem 1983;94:137–147

    PubMed  CAS  Google Scholar 

  11. Sternby B, Akerstrom B: Immunoreactive pancreatic colipase, lipase and phospholipase A2 in human plasma and urine from healthy individuals. Biochim Biophys Acta 1984;789:164–169

    PubMed  CAS  Google Scholar 

  12. Ueda A, Yamaguchi A, Misaki A, et al: Radioimmunoassay of human pancreatic phospholipase A2. Jpn J Clin Pathol 1988;36(suppl):279 (in Japanese)

    Google Scholar 

  13. Ogawa M, Matsuda Y, Uda K, et al: Clinical evaluation of determination of serum pancreatic phospholipase A2 with monoclonal antibody. Gcndai Iryo 1988;20:3013–3017 (in Japanese)

    Google Scholar 

  14. Hermanek P, Sobin LH: TNM classification of malignant tumours. 4th ed. Springer-Verlag, Berlin. 1987

    Google Scholar 

  15. Caraway WT: A stable starch substrate for the determination of amylase in serum and other body fluids. Am J Clin Pathol 1959;32:97–99

    PubMed  CAS  Google Scholar 

  16. Wallenstein S, Zucker CL, Fleiss JL: Some statistical methods useful in circulation research. Circ Res 1980;47:1–9

    PubMed  CAS  Google Scholar 

  17. Siegel S: Non-parametric statistics for the behavioral sciences. McGraw-Hill Co, New York. 1956

    Google Scholar 

  18. Shakir KMM: Phospholipase A2 activity of post-heparin plasma: A rapid and sensitive assay and partial characterization. Anal Biochem 1981;114:64–70

    Article  PubMed  CAS  Google Scholar 

  19. Katsumata M, Gupta C, Goldman AS: A rapid assay for activity of phospholipase A2 using radioactive substrate. Anal Biochem 1986;154:676–681

    Article  PubMed  CAS  Google Scholar 

  20. Heddrickson HS, Pauk PN: Continuous fluorometirc assay of phospholipase A2 with pyrene-labeled as a substrate. Anal Bioehcm 1981;116:553–558

    Article  Google Scholar 

  21. Thurcn T, Virtanen JA, Lalla M, et al: Fluorometric assay for phospholipase A2 in serum. Clin Chem 1985;31:714–717

    Google Scholar 

  22. Hoffmann GE, Schmidt D, Bastian B, et al: Photometric determination of phospholipase A. J Clin Chem Clin Biochem 1986;24:871–875

    PubMed  CAS  Google Scholar 

  23. Eskola JU, Nevalainen TJ, Lovgren TNE: Time-resolvcd fluoroimmunoassay of human pancreatic phospholipase A2. Clin Chem 1983;29:1777–1780

    PubMed  CAS  Google Scholar 

  24. Kameya A, Hayakawa T, Noda A,et al: Differential determination of scrum isoamylase using an amylase inhibitor and its clinical application. Am J Gastroentcrol 1985;80:54–59

    CAS  Google Scholar 

  25. Hayakawa T, Noda A, Kondo T, et al: Diagnostic usefulness of serum lipase activity measured by enzyme immunoassay in pancreatic diseases. Jpn J Gastrocnterol 1985;82:2809–2815 (in Japanese)

    CAS  Google Scholar 

  26. Ogawa Y, Hayakawa T, Kondo T, et al: Diagnostic value of serum immunoreactive trypsin assay in pancreatic diseases using enzyme immunoassay. Jpn J Gastroenterol 1987;84:74–83 (in Japanese)

    CAS  Google Scholar 

  27. Masoero G, Andriulli A, Bianco A, et al: Diagnostic accuracy of serum cationic trypsinogen estimation of pancreatic diseases. Dig Dis Sci 1982;27:1089–1094

    Article  PubMed  CAS  Google Scholar 

  28. Schmidt D, Hoffmann GE: Activity of phospholipase A compared in scrum of patients with pancreatic and nonpancreatic diseases. Clin Chem 1987;33:594–596

    PubMed  CAS  Google Scholar 

  29. Hamano H, Hayakawa T, Kondo T: Serum immunoreactive elastase in diagnosis of pancreatic disease. A sensitive marker for pancreatic cancer. Dig Dis Sci 1987;32:50–56

    Article  PubMed  CAS  Google Scholar 

  30. Matsuda Y, Ogawa M, Shibata T, et al: Distribution of immunoreactivc pancreatic phospholipase A2 (IPPL-2) in various tissues. Res Commun Pathol Pharmacol 1987;58:281–284

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

This work was supported in part by a research grant for intractable pancreatic disease and a pancreatic cancer grant from the Ministry of Health and welfare of Japan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kitagawa, M., Hayakawa, T., Kondo, T. et al. The diagnostic value of serum pancreatic phospholipase A2 (PLA2) in pancreatic diseases. Gastroenterol Jpn 26, 62–68 (1991). https://doi.org/10.1007/BF02779511

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02779511

Key words

Navigation